AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2005
Mar 22, 2005
29875_dirs_2005-03-22_4d2d4b31-352b-413c-9938-063d7ffaf5f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CORP (CVS)
CIK: 0000064803
Period of Report: 2005-03-18
Reporting Person: BODINE CHRIS W (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-03-18 | Common Stock | M | 40000 | $25.125 | Acquired | 40885 | Direct |
| 2005-03-22 | Common Stock | S | 40000 | $52.5273 | Disposed | 885 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2005-03-18 | Stock Option | $25.125 | M | 40000 | Disposed | 2013-01-09 | Common Stock (40000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 83473 | Indirect |
Footnotes
F1: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan.
F2: Includes dividend reinvestment shares acquired during the course of the year.
F3: Cash exercise funded by Insider.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3